[7] Distinctly, topiramate may potentiate central nervous system depression when co-administered with alcohol, opioids, or benzodiazepines, necessitating cautious dose titration and patient education on operating machinery
Effects on curvature and plaque were not evaluated in the randomized phase but curvature improvements were noted in 23% of patients and plaque reductions in 47% of patients in the open-label phase
a Simultaneous participation in any other clinical trial receiving an investigational medicinal product b Patients who attended the final scheduled visit c Patients who completed treatment with assigned treatment according to the end-of-trial form Note: Rescue medication = use of new anti-diabetic medication as add-on to treatment and used for more than 21 days with the initiation at or after randomization and before last day on treatment Table 25: Patient Disposition (CVOT) CV = cardiovascular
A trial could plausibly show sustained appetite suppression and weight loss (the appetite arm holding) alongside a fading gastric-emptying delay (the motor arm adapting)
The product information for semaglutide and liraglutide includes warnings about acute pancreatitis (a known, uncommon adverse effect) but does not list pancreatic cancer as an established risk
Make sure to wash your hands thoroughly after disposing of the GLP-1 patch
-1775582746855.png&w=3840&q=75)
